IM Cannabis (IMCC) Cash from Operations (2020 - 2026)
IM Cannabis' (IMCC) quarterly Cash from Operations came in at 135632.26 in Q1 2026, down 104.36% year-on-year from 3110338.23 in Q1 2025, and down 104.48% quarter-over-quarter from 3029689.55 in Q4 2025.
IM Cannabis (IMCC) Cash from Operations (2020 - 2026) Analysis & Trends
IM Cannabis' Cash from Operations history runs 7 years deep, the most recent figure standing at 135632.26 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 104.36% year-over-year to 135632.26 in Q1 2026; TTM through Mar 2026 was 10196.32, a 99.64% decrease from a year earlier, with the FY2025 full-year figure at 3381778.91, up 529.9% from the prior year.
- Cash from Operations slipped to 135632.26 in Q1 2026 per IMCC's latest filing, from 3029689.55 in the prior quarter.
- Across five years, Cash from Operations topped out at 3994457.67 in Q3 2023 and bottomed at 7455016.23 in Q1 2022.
- The 5-year median for Cash from Operations is 342091.72 (2025), against an average of 790219.25.
- Across the five-year window, Cash from Operations plunged 1777.15% in 2024 and jumped 766.33% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 1854281.3 in 2022, then soared by 91.36% to 160128.74 in 2023, then plunged by 1777.15% to 3005850.54 in 2024, then soared by 200.79% to 3029689.55 in 2025, then tumbled by 104.48% to 135632.26 in 2026.
- Per Business Quant, the three latest IMCC Cash from Operations figures stand at 135632.26 (Q1 2026), 3029689.55 (Q4 2025), and 2541769.24 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -135,632.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135,632.26 |
| Mar 31, 2026 | -135,632.26 |
| Dec 31, 2025 | 3.03 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | -2.54 Mn |
| Sep 30, 2025 | -2.54 Mn |
| Jun 30, 2025 | -342,091.72 |
| Jun 30, 2025 | -342,091.72 |
| Mar 31, 2025 | 3.11 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | -3.01 Mn |
| Dec 31, 2024 | -3.01 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 728,947.13 |
| Jun 30, 2024 | 728,947.13 |
| Mar 31, 2024 | -466,789.21 |
| Mar 31, 2024 | -466,789.21 |
| Dec 31, 2023 | -160,128.74 |
| Dec 31, 2023 | -160,128.74 |